Your landing page’s weakest score is CTA.
How Iambic Therapeutics ranks
- 1.
Charm Therapeutics57
- 2.
Micropep Technologies56
- 3.
Insilico Medicine54
- 4.
Iambic Therapeutics52
- 5.
AgPlenus49
- 6.
Bindwell28
CTA
42PoorCopy, size, verb, cost-feel — does the primary CTA earn the click?

Problems
- no CTA anywhere in either fold
- nav 'Contact' is only action, undifferentiated
- hero ends with text, no next step
Trust
42PoorProof that the product is real, competent, and safe to try.



| Trust read | |
|---|---|
| Iambic Therapeutics | No visible trust signal identified. |
| No visible trust signal identified. | |
| "Our Innovation" list detailing the platform: "Scanning billions of compounds", "De novo design of small molecules" | |
| Pipeline table rows showing "Out-licensed to Exelixis" and "Out-licensed to Menarini" with Phase I–III progress bars and | |
| No visible trust signal identified. | |
| Headline "Addressing resistance in AML with a best-in-class menin inhibitor" naming a specific target and indication |
Value props
54FairTitle, subtitle, hero — do they sell the product's true value?
Better technology for better medicines
Our molecular superintelligence platform delivers differentiated drug candidates, optimized for patient and partner impact
Working
Could improve
Mobile web
58FairThe phone experience as a first-class citizen.

What works
What to improve
Information hierarchy
62FairDoes the design help or inhibit what the page is trying to say?

What works
What to improve
